247 related articles for article (PubMed ID: 35184601)
1. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Modifications in Head and Neck Cancer.
Gaździcka J; Gołąbek K; Strzelczyk JK; Ostrowska Z
Biochem Genet; 2020 Apr; 58(2):213-244. PubMed ID: 31712935
[TBL] [Abstract][Full Text] [Related]
3. High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.
Ghiani L; Chiocca S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408843
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
Castilho RM; Squarize CH; Almeida LO
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
[TBL] [Abstract][Full Text] [Related]
5. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
6. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
Murali M; Saloura V
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
[TBL] [Abstract][Full Text] [Related]
8. Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines.
Atri S; Nasoohi N; Hodjat M
Curr Mol Pharmacol; 2021; 14(1):60-67. PubMed ID: 32394848
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation association with stage progression of head and neck squamous cell carcinoma.
Ghafarpour V; Khansari M; Banaei-Moghaddam AM; Najafi A; Masoudi-Nejad A
Comput Biol Med; 2021 Jul; 134():104473. PubMed ID: 34034219
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
12. Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data.
Zohud O; Lone IM; Nashef A; Iraqi FA
Animal Model Exp Med; 2023 Dec; 6(6):537-558. PubMed ID: 38129938
[TBL] [Abstract][Full Text] [Related]
13. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
14. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
Dlamini Z; Alaouna M; Mbatha S; Bhayat A; Mabongo M; Chatziioannou A; Hull R
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804181
[TBL] [Abstract][Full Text] [Related]
15. Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape.
Romanowska K; Sobecka A; Rawłuszko-Wieczorek AA; Suchorska WM; Golusiński W
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33375464
[TBL] [Abstract][Full Text] [Related]
16. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
[TBL] [Abstract][Full Text] [Related]
17. EPIGENETIC ALTERATIONS DRIVING ONCOGENESIS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA.
Yasothkumar D; Ramalingam K; Ramani P
Exp Oncol; 2023 Dec; 45(3):393-396. PubMed ID: 38186015
[TBL] [Abstract][Full Text] [Related]
18. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
[TBL] [Abstract][Full Text] [Related]
19. Role of epigenetics in OSCC: an understanding above genetics.
Vatsa PP; Jindal Y; Bhadwalkar J; Chamoli A; Upadhyay V; Mandoli A
Med Oncol; 2023 Mar; 40(4):122. PubMed ID: 36941511
[TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA
Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
